Register to get unlimited access to our investor forum and all editorial content, including our e-zine and weekly email. Registration is free and only takes a minute.
Showing fund managers & funds available in Investment Trust Insider. View fund & fund manager rankings globally
F&C marks birthday re-issuing shares for first time in 60 years

F&C marks birthday re-issuing shares for first time in 60 years

Investors gave F&C Investment Trust a big present for its 150th birthday last year, with a re-rating that enabled the £3.7 billion global investment trust to issue its first shares in six decades.

Funds & Fund Managers

All calculations in GBP, unless stated
over :
 Average Manager Total Return : 4.2% (31 March 2018 - 31 March 2019)
Total Return
1 of 165

13.6%

1 of 165

13.6%

3 of 165

11.1%

4 of 165

10.8%

5 of 165

9.6%

6 of 165

9.5%

7 of 165

8.9%

7 of 165

8.9%

9 of 165

8.6%

9 of 165

8.6%

9 of 165

8.6%

12 of 165

8.4%

12 of 165

8.4%

14 of 165

8.2%

15 of 165

8.0%

15 of 165

8.0%

17 of 165

7.7%

18 of 165

7.7%

19 of 165

7.3%

20 of 165

7.3%

21 of 165

7.2%

22 of 165

7.2%

23 of 165

6.8%

24 of 165

6.8%

24 of 165

6.8%

24 of 165

6.8%

24 of 165

6.8%

24 of 165

6.8%

29 of 165

6.7%

30 of 165

6.7%

30 of 165

6.7%

30 of 165

6.7%

33 of 165

6.3%

34 of 165

6.2%

35 of 165

6.2%

35 of 165

6.2%

37 of 165

6.1%

38 of 165

6.0%

38 of 165

6.0%

40 of 165

6.0%

41 of 165

5.9%

42 of 165

5.8%

43 of 165

5.8%

44 of 165

5.8%

45 of 165

5.6%

45 of 165

5.6%

47 of 165

5.5%

48 of 165

5.5%

49 of 165

5.4%

49 of 165

5.4%

49 of 165

5.4%

52 of 165

5.3%

53 of 165

5.3%

53 of 165

5.3%

55 of 165

5.2%

56 of 165

5.0%

57 of 165

5.0%

57 of 165

5.0%

57 of 165

5.0%

60 of 165

4.9%

61 of 165

4.8%

62 of 165

4.8%

63 of 165

4.7%

64 of 165

4.7%

64 of 165

4.7%

66 of 165

4.7%

67 of 165

4.7%

68 of 165

4.5%

69 of 165

4.5%

70 of 165

4.5%

71 of 165

4.4%

71 of 165

4.4%

73 of 165

4.4%

73 of 165

4.4%

75 of 165

4.4%

76 of 165

4.3%

77 of 165

4.3%

77 of 165

4.3%

79 of 165

4.2%

79 of 165

4.2%

81 of 165

4.2%

82 of 165

4.1%

82 of 165

4.1%

82 of 165

4.1%

85 of 165

4.1%

86 of 165

4.1%

87 of 165

4.0%

88 of 165

4.0%

88 of 165

4.0%

90 of 165

3.8%

91 of 165

3.7%

92 of 165

3.7%

93 of 165

3.6%

94 of 165

3.5%

95 of 165

3.4%

95 of 165

3.4%

95 of 165

3.4%

98 of 165

3.3%

99 of 165

3.3%

100 of 165

3.2%

101 of 165

3.2%

101 of 165

3.2%

103 of 165

3.2%

103 of 165

3.2%

103 of 165

3.2%

106 of 165

3.2%

107 of 165

3.1%

107 of 165

3.1%

109 of 165

3.1%

110 of 165

2.9%

110 of 165

2.9%

112 of 165

2.9%

113 of 165

2.8%

114 of 165

2.7%

114 of 165

2.7%

116 of 165

2.7%

117 of 165

2.7%

118 of 165

2.6%

118 of 165

2.6%

120 of 165

2.5%

121 of 165

2.4%

122 of 165

2.3%

122 of 165

2.3%

122 of 165

2.3%

125 of 165

2.3%

126 of 165

2.3%

127 of 165

2.1%

128 of 165

2.1%

129 of 165

2.1%

130 of 165

2.1%

131 of 165

2.1%

131 of 165

2.1%

133 of 165

2.0%

133 of 165

2.0%

135 of 165

2.0%

135 of 165

2.0%

137 of 165

1.9%

137 of 165

1.9%

137 of 165

1.9%

137 of 165

1.9%

141 of 165

1.9%

142 of 165

1.9%

143 of 165

1.7%

144 of 165

1.1%

145 of 165

0.6%

145 of 165

0.6%

145 of 165

0.6%

148 of 165

0.5%

149 of 165

0.3%

150 of 165

-0.2%

151 of 165

-0.2%

151 of 165

-0.2%

153 of 165

-0.9%

153 of 165

-0.9%

155 of 165

-0.9%

155 of 165

-0.9%

157 of 165

-1.3%

158 of 165

-1.8%

159 of 165

-2.5%

159 of 165

-2.5%

161 of 165

-2.8%

161 of 165

-2.8%

163 of 165

-2.9%

164 of 165

-3.1%

165 of 165

-4.9%

Managers with less than 12 months history are below. View 1 month performance
Show more managers
Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated). Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.

GlaxoSmithKline leads FTSE higher on Pfizer tie-up

Fund managers welcome assurances over dividend as GlaxoSmithKline announces plan to hive off consumer healthcare business into joint venture with Pfizer.

AJ Bell shares surge 38% on stock market debut

Shares in online stockbroker jump 38% in conditional trading, surging to £866 million market cap as investors bid up price.

Genevra Banszky von Ambroz: why I like investment trusts

Partner at Smith & Williamson explains why investment trusts and companies are vital components in her clients’ portfolios.

Premier's Hambidge buys into Mobius' trust

Premier multi-asset manager David Hambidge has sold out of Fiera Magna Global Emerging Markets Dividend to buy into Mark Mobius' new investment trust.

Stock market slump: buy the dip or hold steady?

Buying into stock market falls has proved a successful strategy in recent years, but some investors are now taking a more cautious view.

Baillie Gifford takes the axe to Schroders' UK Growth stocks

Edinburgh fund group has implemented a dramatic overhaul to the former Schroder UK Growth portfolio it inherited.

Schroder ISA investors in Baillie Gifford UK Growth given three months to switch

Nearly a quarter of investors who hold their shares in a Schroders’ ISA administered by trust's former fund manager have three months to switch to a new plan manager.

Fund managers lose patience with Woodford's trust

Fund managers at Hawksmoor and Premier have sold their stakes in Woodford Patient Capital as the investment trust continues to struggle.

Hawksmoor: why we joined British Empire at Oakley

A deep discount and signs of management turning over a new leaf drew bargain hunters at Hawksmoor into Oakley Capital Investments alongside British Empire investment trust.

Schroder UK Growth ISA investors in dark over future

Underperforming investment trust will be ineligible for Schroders’ ISA scheme after switching to Baillie Gifford, adding to uncertainty facing nearly one in four of its shareholders.